Manufacturing Establishments1
FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.
SpecGx LLC
163205300
Products2
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Morphine Sulfate
Product Details
Morphine Sulfate
Product Details
Drug Labeling Information
Complete FDA-approved labeling information including indications, dosage, warnings, contraindications, and other essential prescribing details.
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
PRINCIPAL DISPLAY PANEL - 30 mg Bottle
NDC 0406-5119-01
100 TABLETS
Morphine Sulfate
Tablets
CII
30 mg
Rx only
PHARMACIST: Dispense the Medication Guide provided separately to each patient.
Mallinckrodt™
L0M144
Rev 03/2023

RECENT MAJOR CHANGES SECTION
RECENT MAJOR CHANGES
Boxed Warning |
12/2023 |
Indications and Usage (1) |
12/2023 |
Dosage and Administration (2.1, 2.3, 2.4) |
12/2023 |
Warnings and Precautions (5.6) |
12/2023 |
DESCRIPTION SECTION
11 DESCRIPTION
Morphine Sulfate Tablets are an opioid agonist, available for oral administration:
- 15 mg tablet: Each tablet contains 15 mg of morphine sulfate, USP (equivalent to 11.25 mg morphine).
- 30 mg tablet: Each tablet contains 30 mg of morphine sulfate, USP (equivalent to 22.5 mg morphine).
Chemically, morphine sulfate is 7,8-didehydro-4,5α-epoxy-17-methylmorphinan-3,6α-diol sulfate (2:1) (salt) pentahydrate. Morphine sulfate, USP is a white to off-white crystalline powder or a fine white to light yellow powder. It is soluble in water and slightly soluble in alcohol, but is practically insoluble in chloroform or ether. The octanol: water partition coefficient of morphine is 1.42 at physiologic pH and the pka is 7.9 for the tertiary nitrogen (the majority is ionized at pH 7.4). Its molecular formula is (C17H19NO3)2 • H2SO4 • 5H2O, and it has the following chemical structure:

Each tablet contains 15 or 30 mg of morphine sulfate, USP and the following inactive ingredients: Microcrystalline Cellulose (Avicel PH 102), Corn Starch, Pregelatinized Starch, Magnesium Stearate, Colloidal Silicon Dioxide, and Stearic Acid 50 Powder.
DOSAGE FORMS & STRENGTHS SECTION
Highlight: Tablets: 15 mg and 30 mg. (3)
3 DOSAGE FORMS AND STRENGTHS
- Each 15 mg tablet for oral administration contains: 15 mg morphine sulfate USP (equivalent to 11.25 mg morphine) and is a white, biconvex tablet, debossed “M” on one side, and “15” with a score on the other side.
- Each 30 mg tablet for oral administration contains: 30 mg morphine sulfate USP (equivalent to 22.5 mg morphine) and is a white, biconvex tablet, debossed “M” on one side, and “30” with a score on the other side.
CONTRAINDICATIONS SECTION
Highlight: * Significant respiratory depression. (4)
- Acute or severe bronchial asthma in an unmonitored setting or in absence of resuscitative equipment. (4)
- Concurrent use of monoamine oxidase inhibitors (MAOIs) or use of MAOIs within the last 14 days. (4)
- Known or suspected gastrointestinal obstruction, including paralytic ileus. (4)
- Hypersensitivity to morphine. (4)
4 CONTRAINDICATIONS
Morphine sulfate tablets are contraindicated in patients with:
- Significant respiratory depression [see Warnings and Precautions (5.2)].
- Acute or severe bronchial asthma in an unmonitored setting or in the absence of resuscitative equipment [see Warnings and Precautions (5.7)].
- Concurrent use of monoamine oxidase inhibitors (MAOIs) or use of MAOIs within the last 14 days [see Warnings and Precautions (5.8) and Drug Interactions (7)].
- Known or suspected gastrointestinal obstruction, including paralytic ileus [see Warnings and Precautions (5.12)].
- Hypersensitivity to morphine (e.g., anaphylaxis) [see Adverse Reactions (6)].
BOXED WARNING SECTION
**WARNING: SERIOUS AND LIFE-THREATENING RISKS FROM USE OF MORPHINE SULFATE
TABLETS**
SPL MEDGUIDE SECTION
MEDICATION GUIDE
Medication Guide Morphine Sulfate (mor’ feen sul’ fate) Tablets CII Rx only | |
Morphine sulfate tablets are:
| |
Important information about morphine sulfate tablets: *Get emergency help or call 911 right away if you take too many morphine sulfate tablets (overdose). When you first start taking morphine sulfate tablets, when your dose is changed, or if you take too much (overdose), serious or life-threatening breathing problems that can lead to death may occur. Talk to your healthcare provider about naloxone, a medicine for the emergency treatment of an opioid overdose.
| |
Do not take morphine sulfate tablets if you have:
| |
Before taking morphine sulfate tablets, tell your healthcare provider if you have a history of: | |
|
|
|
|
| |
Tell your healthcare provider if you are: ***noticing your pain getting worse.**If your pain gets worse after you take morphine sulfate tablets, do not take more of morphine sulfate tablets without first talking to your healthcare provider. Talk to your healthcare provider if the pain that you have increases, if you feel more sensitive to pain, or if you have new pain after taking morphine sulfate tablets. *pregnant or planning to become pregnant. Use of morphine sulfate for an extended period of time during pregnancy can cause withdrawal symptoms in your newborn baby that could be life-threatening if not recognized and treated. ***breastfeeding.**Morphine sulfate passes into breast milk and may harm your baby. Carefully observe infants for increased sleepiness (more than usual) breathing difficulties, or limpness. Seek immediate medical care if you notice these signs.
| |
When taking morphine sulfate tablets:
| |
While taking morphine sulfate tablets DO NOT:
| |
The possible side effects of morphine sulfate tablets:
Get emergency medical help or call 911 right away if you have:
These are not all the possible side effects of morphine sulfate tablets. Call your healthcare provider for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.For more information go to dailymed.nlm.nih.gov. Manufactured by: SpecGx LLC, Webster Groves, MO 63119 USA, |
This Medication Guide has been approved by the U.S. Food and Drug
Administration. Revised: 12/2023
MG20M58
Pediatric use information is approved for Hikma Pharmaceuticals USA Inc.’s Morphine Sulfate Tablets. However, due to Hikma Pharmaceuticals USA Inc.’s marketing exclusivity rights, this drug product is not labeled with that information.